Case File
efta-efta00850135DOJ Data Set 9OtherFrom: Elie Kobrin
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00850135
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Elie Kobrin
To: 'Jeffrey L Port' <1
jeffrey E. <jeevacation®gmail.com>
Subject: RE: How much is a biotech with no approved drugs worth? Billions, NantKwest investors say
Date: Wed, 29 Jul 2015 13:34:39 +0000
Yup, wild.
Yesterday it basically had the same enterprise value as JUNO.
From: Jeffrey L Port (mallto:
Sent: Wednesday, July 29, 2015 9:31 AM
To: Die Kobrin; Jeffrey E.
Subject: How much is a biotech with no approved drugs worth? Billions, NantKwest investors say
A cell therapy company founded by a surgeon who is a serial entrepreneur
Here is something from WSJ.com that might interest you:
How much is a biotech with no approved drugs worth? Billions, NantKwest investors say
http://on.wsj.com/I.LPOiClA
This communication is intended only for the addressee(s) and may contain confidential information. We do not
waive any confidentiality by misdelivery. If you receive this communication in error, any use, dissemination,
printing or copying is strictly prohibited; please destroy all electronic and paper copies and notify the sender
immediately.
EFTA00850135
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comURL
http://on.wsj.com/I.LPOiClAForum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.